Andrew Seid
Analyst
Jefferies
Equibles does not estimate personal net worth.
About Andrew Seid
Andrew Seid is recorded as Analyst at Jefferies. Andrew Seid has spoken on 1 earnings call across 1 company, most recently for Axsome Therapeutics, Inc. on November 2, 2026. The companies whose calls Andrew Seid spoke on are classified in the Healthcare sector.
Andrew Seid on recent calls
“The NBRX data for the 65-plus age group looks quite healthy, I think 99% quarter to quarter. So, when do you think the NBRX inflection will meaningfully cash up to TRX exactly?”
Affiliation history
-
Jefferies
Analyst
Transcript header (unverified)
Current